Cannabidiol

Cannabis Research & Industry News Highlights

On: December 17, 2018

In: Business, Cannabidiol, CBD, Regulation, Research, Safety

Here’s what’s happening today in the world of CBD research, products and announcements: It’s Time To Remove Cannabis From The Federal Drug Schedules “One reason there has been so little in the United States is precisely because cannabis is listed on Schedule I, a designation that creates significant barriers toRead More →

Cannabidiol Yields Dose-Dependent Control Over Seizures for Children and Adults

By: CRF Editors

On: December 13, 2018

In: Cannabidiol

The effectiveness of Epidiolex for the treatment of certain kinds of epilepsy in both children and adults is dose-dependent, according to a recent report in MD Magazine. “There was a linear relationship between the cannibidol dose and the plasma levels of the drug, and higher plasma levels were associated withRead More →

Copyright 2019. Cannabis Research Forum. All Rights Reserved.

Disclaimer: Cannabis Research Forum (CRF) has no affiliation or relationship with any business, project or event unless explicitly stated otherwise. CRF is only an informational website that provides news about scientific research, products and updates related to cannabis, hemp and cannabinoids, None of the information you read on CRF should be taken as investment advice. Please conduct your own due diligence before making any investment or medical decisions. CRF is not accountable, directly or indirectly, for any damage or loss incurred, alleged or otherwise, in connection to the use or reliance of any content you read on the site.

Top Menu

Search

Cannabidiol

Cannabis Research & Industry News Highlights

Cannabidiol Yields Dose-Dependent Control Over Seizures for Children and Adults